The findings suggest that immune cells and metabolites may have genetically predicted effects on fracture risk, with metabolites potentially serving as key mediators. Critical pathways, hub genes, and fracture-associated SNPs were identified, along with potential epigenetic regulation via methylation sites. These preliminary insights offer novel directions for future research into the underlying mechanisms of fracture risk and intervention.
Wan et al. (Thu,) studied this question.